AzTrials
AzTrials

Attention-Deficit/Hyperactivity Disorder (ADHD)THRIVE Phase 1NCT07894094

Phase 1: Thrive Together: A Feasibility and Acceptability Evaluation of Peer Mentoring for High Schoolers With ADHD and Their Caregivers

An observational study of Attention-Deficit/Hyperactivity Disorder (ADHD), run by Boston Children's Hospital at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

During this first phase of the study, we are conducting focus group to conduct a needs assessment. Specifically, we will be holding focus groups with adolescents with ADHD as well as separate focus groups with the adolescents' parents to better understand the current needs of youth with ADHD and how to best support… Read more about this study

Who is it for?
Ages 13 to 18 years
How many people
40 participants
Where
1 siteUnited States
Study dates
31 Oct 2026to 1 Mar 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: We will be recruiting 13-17 year old youth with ADHD as well as their caregivers.

Who may be able to join

  • ADHD diagnosis, English speaking, available on date of focus group, Resident in MA

Who cannot join

  • Intellectual Disability diagnosis, Autism Spectrum Disorder diagnosis, in Department of Children and Families custody, Caregiver not available,

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Virginia D Peisch, PhD contact

774-487-4092

virginia.peisch@childrens.harvard.edu

United States1 site

  • 2 Brookline Place

    Brookline, Massachusetts, 02445

    Virginia D Peisch, PhD, 7744874092, virginia.peisch@childrens.harvard.edu

Other trials in United States

About this study

During this first phase of the study, we are conducting focus group to conduct a needs assessment. Specifically, we will be holding focus groups with adolescents with ADHD as well as separate focus groups with the adolescents' parents to better understand the current needs of youth with ADHD and how to best support them.

Read the detailed description

Attention deficit hyperactivity disorder (ADHD) is a common chronic childhood condition, affecting approximately 10% of youth in the U.S. Despite advancements in evidence-based pharmacological and behavioral treatments, youth with ADHD continue to experience significant functional impairment across multiple domains. This Pilot Project, THRIVE (Thriving with Healthy Routines, Interpersonal Skills, and ExecutiVE-Functioning), will improve access to evidence-based psychoeducation and social support for families through the implementation and evaluation of a peer-facilitated support group intervention for youth with ADHD and their caregivers. In Phase 1 of this study, we will collaborate with youth with ADHD and their caregivers to refine our evidence- informed curriculum, ensuring that content, format, and delivery are responsive to their lived experiences.

Keywords
Attention-Deficit/Hyperactivity Disorder (ADHD), Focus groups, Needs assessment, youth and families
Medical subject headings
Attention Deficit Disorder with Hyperactivity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rapid qualitative analysis

    We will conduct a rapid qualitative analysis in order to synthesize the qualitative feedback from the focus groups

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2026
  2. Study start31 Oct 2026 (estimated)
  3. Primary completion1 Feb 2027 (estimated)
  4. Study completion1 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07894094
Sponsor's protocol ID
P00055732
Acronym
THRIVE Phase 1
Status last verified
Oct 2026
First submitted
19 Oct 2026
Last updated
26 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bibliography: 1. Danielson, M.L., et al., ADHD Prevalence among US children and adolescents in 2022: Diagnosis, severity, co-occurring disorders, and treatment. Journal of Clinical Child & Adolescent Psychology, 2024: p. 1-18. 2. Evans, S.W., et al., Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder. Journal of Clinical Child & Adolescent Psychology, 2018. 47(2): p. 157-198. 3. Mechler, K., et al., Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacology & Therapeutics, 2022. 230: p. 107940. 4. Arnold, L.E., et al., Long-term outcomes of ADHD: Academic achievement and performance. Journal of Attention Disorders, 2020. 24(1): p. 73-85. 5. Dodds, M., et al., Economic burden and service utilization of children with Attention-Deficit/Hyperactivity disorder: a systematic review and Meta-analysis. Value in Health, 2024. 27(2): p. 247-264. 6. Harstad, E.B., et al., Children with ADHD are at risk for a broad array of adverse adult outcomes that cross functional domains: Results from a population-based birth cohort study. Journal of attention disorders, 2022. 26(1): p. 3-14. 7. Meyer, J., et al., Associated predictors of functional impairment among adolescents with ADHD-A cross-sectional study. Child Adolescent Psychiatry and Mental Health, 2022. 16(1): p. 29. 8. Overgaard, K.R., et al., Functional impairment related to ADHD from preschool to school age. Journal of Attention Disorders, 2025. 29(3): p. 220-230. 9. Ros, R. and P.A. Graziano, Social functioning in children with or at risk for attention deficit/hyperactivity disorder: A meta-analytic review. Journal of Clinical Child & Adolescent Psychology, 2018. 47(2): p. 213-235. 10. Zhao, X., et al., Family burden of raising a child with ADHD. Journal of Abnormal Child Psychology, 2019. 47: p. 1327-1338. 11. Roizen, N.J., et al., Adaptive functioning in children with attention-deficit hyperactivity disorder. Arch Pedia

Questions about this trial

What is this clinical trial studying?

An observational study of Attention-Deficit/Hyperactivity Disorder (ADHD), run by Boston Children's Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Virginia D Peisch, PhD (774-487-4092, virginia.peisch@childrens.harvard.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rapid qualitative analysis (time frame: 2 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07894094, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026; AzTrials last refreshed its copy on 27 Oct 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in